Skip to content

Seated Baduanjin Exercise for Improving Sleep in Breast Cancer Patients Receiving Chemotherapy

Study on Sleep Disorders in Breast Cancer Patients Undergoing Chemotherapy: Risk Prediction Model and Evaluation of Experimental Protocol

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000338
Enrollment
Unknown
Registered
2026-02-09
Start date
2026-03-01
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep Disorders in Breast Cancer Patients Undergoing Chemotherapy

Interventions

Intervention Group (Baduanjin Exercise):In addition to routine care, patients will be guided to practice seated Baduanjin exercise, 30 minutes per session, 3 times per week, for 12 consecutive weeks.
Control Group (Routine Care):Receive routine care without Baduanjin exercise intervention.

Sponsors

Nanxishan Hospital of Guangxi Zhuang Autonomous Region
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Pathologically confirmed breast cancer patients currently undergoing chemotherapy; Female, aged = 18 years; Able to understand and complete the questionnaires independently; Willing to participate in the study and sign the informed consent form; For participants entering the intervention stage: identified as high-risk individuals for sleep disorders by the prediction model and able to perform seated Baduanjin (mild, low-intensity) exercise.

Exclusion criteria

Exclusion criteria: Patients with severe psychiatric disorders, cognitive impairment, or neurological diseases who are unable to cooperate with the study; Patients with other malignant tumors or severe dysfunction of major organs such as the heart, lungs, liver, or kidneys; Currently participating in other interventional exercise studies that may interfere with this study; Pregnant or breastfeeding women; Any other condition considered unsuitable for participation by the investigators.

Design outcomes

Primary

MeasureTime frame
Sleep Quality (Pittsburgh Sleep Quality Index, PSQI total score);

Secondary

MeasureTime frame
Fatigue (Brief Fatigue Inventory, BFI total score);Quality of Life (Functional Assessment of Cancer Therapy-Breast, FACT-B total score);Pain (Numeric Rating Scale, NRS 0–10);

Countries

China

Contacts

Public ContactYi Xu

Nanxishan Hospital of Guangxi Zhuang Autonomous Region

878557606@qq.com18377115934

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Mar 14, 2026